RELEASE: Official Opening of Scivita Medical Headquarters and R&D Facility (2)

SUZHOU, China, June 2, 2023/PRNewswire/ -- On June 2, 2023 (Beijing time), Scivita Medical's headquarters, R&D plant and manufacturing plant were officially opened in Suzhou Industrial Park. Suzhou (SIP). This momentous occasion marks an important milestone for Scivita Medical as it consolidates its key operations, spanning RD, production, marketing, physician training, product exposure, and experiential activities. The establishment of the plant will serve as a solid foundation for Scivita Medical to enhance its R&D and sales capabilities, increase its production capacity and improve the competitiveness of its products. It reflects Scivita Medical's commitment to its core strategy of “going global”.

On that day, the ceremony was attended by Shen Mi, Suzhou CPC Standing Committee member and CPC SIP Working Committee secretary, Liu Hua and Zou Xiaowei, CPC SIP Working Committee members and SIP Administrative Committee deputy directors, Dr. Zhang Yi, Co-Founder of Scivita Medical and Chairman of the Board, Dr. Chin To, Co-Founder of Scivita Medical, CEO, CTO, Officials from the SIP Economic Development Commission, the Investment Promotion Commission, the Scientific and Technological Innovation Commission, the Office of Market Supervision and Administration and the Zone of High-end Manufacturing and International Trade, representatives of shareholders and important partners of Scivita Medical.

Dr. Chin To, Co-Founder, CEO and CTO of Scivita Medical, said: "The new headquarters, RD facility and manufacturing facility mark an important milestone in Scivita Medical's journey and will greatly contribute to enhance the overall strength of Scivita Medical in all aspects It will give a significant boost to our production capacity, allowing us to meet growing market demand and offer more innovative and higher quality products In addition, the facility will greatly support the training and development of our internal and external professionals, further raising the standards and independent growth of China's endoscopy industry and accelerating the pace of "globalization".

New Update: Energize the Power of the Enterprise

As the heart of Scivita Medical's future global footprint, the design of the new facility considered both hardware elements, such as functional planning, and software aspects, such as humanistic care, with the goal of strike a balance between capacity expansion, market cultivation and employee welfare. The four-storey main building encompasses functional areas such as warehouse, offices, clean and unclean workshop, with each area relatively independent from each other to ensure orderly and efficient production and operation. The annex building, which houses the cafeteria and the training center, serves as a space dedicated to external visits and internal training sessions.

In addition, the renovation works of the vocational training center will start at the end of 2023. It includes exhibition halls, conference centers, surgical training centers and simulation training centers. This will greatly support Scivita Medical's continued efforts to cultivate the endoscope market. Internally, it will enhance the professional capacity of employees. Externally, it will enhance physicians' knowledge of the latest endoscopy technologies and techniques. This will facilitate productive conversations with physicians and experts, allowing us to address clinical needs and optimize our products, thus promoting the development of collaboration between the medical industry, academia and research.

In addition, the office and production spaces of the new plant have functional sections, such as the "Hallway Bar" and the "Recreational Area", designed to offer employees spaces for leisure and stress relief. Production workshops are equipped with separate changing rooms for male and female employees, along with essential facilities such as lactation rooms and changing rooms to meet the specific needs of female employees, further demonstrating Scivita Medical's value of "People Orientation." ".

Globalization: accelerating the journey to the world market

As the leading national endoscope company, Scivita Medical has consistently aspired to a strong global presence. In the global market, the medical endoscope market is one of the fastest growing within the medical device market. With a market value of $20.3 billion in 2020, the global market for medical endoscopes is anticipated to reach $39.6 billion by 2030. Expansion in the global market means an abundance of opportunities for Scivita Medical to pursue further development. .

Since its founding, Scivita Medical has embraced "Globalization" as its core strategy, with the goal of becoming the preferred brand trusted by doctors and patients around the world. Over the years, Scivita Medical endoscopes have gained the competitive edge needed to thrive in the global marketplace. The superior quality of Scivita Medical products has garnered significant recognition in both the domestic and international markets, with multiple products achieving FDA, CE, and PDMA certifications.

Scivita Medical has established R&D centers in both China and Japan, attracting many local talents in this field. The official opening of Scivita Medical's headquarters, RD facility and manufacturing facility will further strengthen its extensive innovation, RD and manufacturing capabilities on a global scale. With an already established presence in key global markets such as Europe, North America and Japan, Scivita Medical continues to expand its national and international sales network through strategic collaborations with renowned international medical device companies. In addition, Scivita Medical has actively participated in international industry exhibitions and academic conferences to enhance the presence of its products in the national and international markets.

About Scivita Medical

Founded in 2016, Scivita Medical is a medical device company that provides minimally invasive diagnostic and treatment solutions, focusing on the research, development, and commercialization of medical endoscopes and related products. Scivita Medical takes 'Globalization' as its core strategy and has established R&D centers in both China and Japan. With strong in-house R&D capabilities, Scivita Medical has established a unique technology platform based on five synergistic core technologies, and has created a comprehensive portfolio of endoscopic products and product candidates covering all types of endoscopic procedures performed by the various clinical departments, to address various medical needs. Adhering to its value of "Clinical Focus", "Collaborative Innovation", "People Orientation", "Excellence and Efficiency", Scivita Medical will continuously upgrade its core technologies, improve market penetration with excellent products and become the preferred brand trusted by doctors and patients around the world.

For more information, visit: scivitamedical.com/

Photo - https://mma.prnewswire.com/media/2091784/Launching_ceremony_Scivita_Medical_s_Headquarters_R_D_Manufacturing_Plant.jpgPhoto - https://mma.prnewswire.com/media/2091785/Dr_Chin_To_Scivita_Medical_s_co_founder_General_Manager_Chief_Technology.jpgPhoto - https://mma.prnewswire.com/media/ 2091786/1. jpg

View original content: https://www.prnewswire.com/news-releases/inauguracion-oficial-de-la-sede-central-y-la-planta-de-id-y-fabricacion-de-scivita-medical-301841374.html